Acurx Pharmaceuticals, Inc. (ACXP): Price and Financial Metrics
ACXP Price/Volume Stats
Current price | $0.37 | 52-week high | $3.33 |
Prev. close | $0.37 | 52-week low | $0.30 |
Day low | $0.36 | Volume | 137,339 |
Day high | $0.38 | Avg. volume | 290,332 |
50-day MA | $0.40 | Dividend yield | N/A |
200-day MA | $1.19 | Market Cap | 8.76M |
ACXP Stock Price Chart Interactive Chart >
Acurx Pharmaceuticals, Inc. (ACXP) Company Bio
Acurx Pharmaceuticals, LLC, a clinical stage biopharmaceutical company, develops antibiotics to treat bacterial infections. Its lead antibiotic candidate is ibezapolstat, a novel mechanism of action that targets the polymerase IIIC enzyme that has completed Phase II clinical trial to treat patients with clostridium difficile infections. The company is also developing ACX-375C, a potential oral and parenteral treatment targeting gram-positive bacteria, including methicillin-resistant staphylococcus aureus, vancomycin-resistant enterococcus, and penicillin-resistant streptococcus pneumoniae. The company was founded in 2017 and is based in Staten Island, New York.
ACXP Price Returns
1-mo | -2.63% |
3-mo | -50.13% |
6-mo | -78.49% |
1-year | -83.56% |
3-year | -86.30% |
5-year | N/A |
YTD | -54.55% |
2024 | -78.75% |
2023 | -3.77% |
2022 | -7.90% |
2021 | N/A |
2020 | N/A |
Loading social stream, please wait...